volume 24, issue s2, P75-94 2011
DOI: 10.3233/jad-2011-110218
View full text
|
Sign up to set email alerts
|
Share

Abstract: Alzheimer's disease (AD) is by far the main cause of dementia in the aged population. Because the amyloid-β peptide (Aβ) is the main component of senile plaques that develop in the brain of affected patients, numerous studies aimed at preventing its production or aggregation were conducted during the past 25 years. The inhibition of Aβ production via pharmacological inhibition of β- and γ-secretases is, with vaccination, one of the two main current challenges aimed at curing AD. However, the fact that there ex…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
21
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals